Valerio Nobili researcher
Nobili, Valerio
VIAF ID: 73153833157564330128 (Personal)
Permalink: http://viaf.org/viaf/73153833157564330128
Preferred Forms
-
- 100 0 _ ‡a Valerio Nobili ‡c researcher
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Non-alcoholic fatty liver and metabolic syndrome in children: a vicious circle. | |
Non-high-density lipoprotein cholesterol | |
Novel large-range mitochondrial DNA deletions and fatal multisystemic disorder with prominent hepatopathy | |
Nutritional considerations in children with chronic liver disease | |
The Obalon swallowable intragastric balloon in pediatric and adolescent morbid obesity | |
Omega-3 fatty acids: Mechanisms of benefit and therapeutic effects in pediatric and adult NAFLD. | |
Paediatric nonalcoholic fatty liver disease. | |
Pediatric liver diseases: current challenges and future perspectives | |
Plasma Cathepsin D Levels: A Novel Tool to Predict Pediatric Hepatic Inflammation | |
Plasma levels of homocysteine and cysteine increased in pediatric NAFLD and strongly correlated with severity of liver damage. | |
Portal hypertension in children | |
Post-transplant metabolic syndrome in children: Know better to cure better | |
Preemptive liver transplantation in a child with familial hypercholesterolemia | |
Profiling microRNA expression: A snapshot of nonalcoholic steatohepatitis and a recording of its pathogenesis | |
Programming, metabolic syndrome, and NAFLD: the challenge of transforming a vicious cycle into a virtuous cycle | |
Psychosocial condition after liver transplantation in children: review of the literature from 2006 to 2008. | |
Recent advances in biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis: the role of lipid analysis/profiling | |
Redox homeostasis and posttranslational modifications/activity of phosphatase and tensin homolog in hepatocytes from rats with diet-induced hepatosteatosis. | |
Relationship between non-alcoholic steatohepatitis, PNPLA3 I148M genotype and bone mineral density in adolescents | |
Retinoids counteract insulin resistance and liver steatosis: What's the potential mechanism? | |
Risk of severe liver disease in NAFLD with normal ALT levels: a pediatric report. | |
Role of Fatty Liver Disease in Childhood Obesity | |
The role of lifestyle changes in the management of chronic liver disease | |
The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications. | |
The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage. | |
Screening of an Echinococcus granulosus cDNA library with IgG4 from patients with cystic echinococcosis identifies a new tegumental protein involved in the immune escape. | |
The SOD2 C47T polymorphism influences NAFLD fibrosis severity: Evidence from case-control and intra-familial allele association studies | |
Statin use and non-alcoholic steatohepatitis in at risk individuals. | |
Steatosis and fibrosis in paediatric liver transplant: insidious graft's enemies--a call for clinical studies and research | |
Successful tenofovir treatment for fulminant hepatitis B infection in an infant | |
T regulatory cell number and function: the autoimmune traits in liver diseases. | |
Targeted therapy in children—what is the right way? | |
Targeting FGF19 binding to its receptor system: A novel therapeutic approach for hepatocellular carcinoma | |
Thyroid function tests in obese prepubertal children: correlations with insulin sensitivity and body fat distribution. | |
Toll-like receptor-mediated signaling cascade as a regulator of the inflammation network during alcoholic liver disease | |
Transient elastography for assessment of fibrosis in paediatric liver disease | |
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease. | |
Treatment of Wilson's disease with zinc from the time of diagnosis in pediatric patients: a single-hospital, 10-year follow-up study. | |
Tyrosinemia type 1: metastatic hepatoblastoma with a favorable outcome. | |
Unraveling the genetics of fatty liver in obese children: Additive effect of P446L GCKR and I148M PNPLA3 polymorphisms | |
Urinary (1)H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment. | |
Use of metformin in pediatric age. | |
The use of ultrasound in clinical setting for children affected by NAFLD: is it safe and accurate? | |
Utility of magnetic resonance imaging in the evaluation of hepatic fat content. | |
Viral hepatitis in children | |
Vitamin D and liver fibrosis: let's start soon before it's too late | |
The wide spectrum of hepatic iron overload | |
β-Klotho gene variation is associated with liver damage in children with NAFLD |